Unit VII GSM

9

Teameco Broughton

Institution: Columbia Southern University

BUS 6320: Global Strategic Management

Instructor: Professor: Robin Shah

Date: 2/11/2026

Johnson & Johnson (J&J) is a multinational healthcare company with over 130 years of history. Since the firm deals with pharmaceuticals, medical devices, and consumer health, the strategic management process should be able to keep adjusting to the dynamic external and internal environments. The analysis also provides a detailed environmental scan of J&J, including macro-, industry-, and competitive-environment analyses; internal capabilities; current strategies; and performance metrics. This is meant to determine how J&J has remained competitive through innovation, strategic planning, and stakeholder participation.

External Environmental Analysis

Macro-Level PESTEL Analysis

     Based on the political analysis, J&J operates in complex regulatory markets across 175 countries, including the United States under FDA regulations and evolving healthcare policies in other countries. There are growth opportunities arising from political stability in emerging markets, though trade policies and intellectual property protection remain issues. Economically, global economic changes affect healthcare expenditure (Day Translations, Inc., 2019). The diversified portfolio helps J&J mitigate downturns, but currency exchange risks and supply chain inflationary pressures remain challenges.

            From a sociocultural perspective, the ageing population and rising health awareness are driving demand for medical equipment and pharmaceuticals. The focus on accessibility and affordability aligns with J&J's societal trend toward fair healthcare. Technologically, digital health, AI, and telemedicine are developing rapidly, and their research and development should continue (Crain, 2023). The innovations that make J&J the leader in MedTech transformations are artificial intelligence in surgery and glucose sensors.

Based on environmental considerations, environmental pressure mandates that the manufacturing and disposal processes for waste materials be environmentally friendly. J&J's ESG (environmental, social, and governance) compliance will help enhance its corporate image. Legally, the potential for future litigation, such as lawsuits related to talc use, poses a threat to finances and reputation (Bird et al., 2021). Global healthcare regulations play an important role in ensuring that the operational licenses are not revoked.

Porter's Five Forces Industry Environment.

· Threat of New Entrants: High barriers to entry due to strict regulations, significant investment in research and development, and existing brand loyalty prevent new entrants from entering the J&J market.

· Supplier Power: Moderate, since J&J's size would enable it to negotiate power, but specialized medical parts might depend on a small number of suppliers.

· Bargaining Power of Buyers: High, particularly institutional buyers (hospitals, governments) that require cost-effective solutions. Product differentiation at J&J will help counteract some of the price sensitivity.

· Threat of substitutes: Moderate due to the presence of generic medicines and other treatment methods; however, J&J has patented medicines and a recognizable brand, which reduces the threat of substitutes.

· Competitive Environment: High, because the company has to deal with such competitors as Medtronic, Pfizer, and Procter & Gamble that operate in the sphere of innovation, pricing, and globalization.

Competitor and Strategic Group Analysis.

J&J is a high-innovation strategic unit, which competes with other businesses, including Roche and Abbott Laboratories, on R&D-based strategic differentiation. Its medical devices division holds the second-largest market share (5.24% in 2018) and competes with Medtronic in cardiovascular devices and Stryker in orthopedics (Day Translations, Inc., 2019). It is determined by the strategic categories of geographic coverage, product diversification, and sustainability promises, and J&J is the pioneer of ESG integration and market penetration worldwide.

Internal analysis of the firm using the resource-based view

Resources, Capabilities, and Competencies.

J&J's tangible resources include manufacturing plants in various countries, research and development centers, and a variety of products. Good brand equity, patents, and stakeholder trust are examples of intangible resources. Its core competencies are its mergers and acquisitions (M&A) experience (with its acquisition of Auris Health) and its innovation pipeline with the J&J Innovation Group (Day Translations, Inc., 2019). The three key competencies include collaboration across all divisions, adaptation to market entry, and the application of digital health technologies.

VRIO Analysis

· Valuable: J&J's supply chain, brand reputation, and R&D output have significant value because they generate income and loyalty in the market.

· Rare: its size and experience in the medical equipment industry are uncommon, as few companies have 130 years of history and a global subsidiary network.

· Hard to imitate: The patented technologies and established relationships with regulations cannot be duplicated quickly by competitors.

· Organized to Capture Value: J&J's decentralized structure enables subsidiaries to be flexible in local environments while aligning with corporate sustainability and innovation objectives, capturing value across markets.

The input of leadership in innovation.

The J&J innovation culture is enabled by its strategic vision and resource distribution, with Gary Pruden as its leader, and the Global Surgery Group is oriented towards technological and professional development. The leaders are the advocates of ESG initiatives, and digital transformation and innovation are consistent with long-term competitive advantage and stakeholder expectations.

Firm’s current business-level and corporate-level strategies

Business-Level Strategy: Product Market Positioning.

J&J employs a broad differentiation strategy, offering high-quality, innovative products across all healthcare segments. Its medical devices unit targets the needs of specific customers (e.g., diabetes control using OneTouch(r) systems), and its quality and technology are very high.

Strategy Implementation and the Sustainability Integration

J&J implements its approaches through decentralized operations. Consequently, it enables regional units to make use of these strategies. ESG structures focus on sustainability, minimizing environmental degradation, and promoting social responsibility (Setyadi et al., 2025). The training of surgeons at the Johnson & Johnson institute is one of these attempts to emulate shared value creation, as it enhances community health and loyalty.

Competitive Advantage of Innovation.

J&J's strategy is about innovation that helps the company differentiate and become more cost-effective. Digital health devices, including AI-based surgical applications, improve patient outcomes and performance. This is sustained by constant investment in research and development that keeps the pipelines at the forefront of developing healthcare markets. This makes J&J a reliable solutions brand.

Firm’s performance

Financial and Market-Based Measures.

· Financial: The medical devices segment of J&J earned total revenue of 27 billion in 2018, and its growth has been consistent, despite market divestitures. J&J's profitability ratios and dividend stability are high, which attracts investors.

· Market-Based: The performance of its stock is resilient, as its market capitalization has consistently ranked among healthcare leaders. Trust and innovation perception also drive brand valuation (Johnson & Johnson, 2023).

Competitor and Industry Comparisons.

J&J beats many of its competitors in terms of revenue diversification and ESG ratings. Nonetheless, other competitors, such as Medtronic, are at the forefront in specific devices. J&J is above the market median in both R&D (13% of sales) and international revenue share (over 50%).

Trends Over 3-5 Years

The trends include a rise in the adoption of digital health, strategic sales of non-core businesses (e.g., LifeScan), and an increase in M&A in robotics and AI. ESG reporting has become more transparent, aligning with global standards such as the GRI Standards.

Stakeholder Perspectives

J&J's training and ethical culture are in the interests of internal stakeholders (employees and managers). J&J is appreciated for its efforts to provide access to its products and to advance sustainability by external stakeholders (patients, governments, communities). Reputational risks, however, are litigation issues.

Competitive Advantage and Sustainability.

The strength of J&J has been the heterogeneity of its resources, its innovation capacity, and its global flexibility. The approach to ensuring its continuity requires it to continue increasing its investments in research and development, become more environmentally responsible, and further integrate its divisions into digital systems (Wu, 2024). It will be important to be strategic in developing markets and to keep stakeholders engaged..

Conclusion

A strong internal structure, based on resources, and an effective external positioning are strong sources of strategic competitiveness for Johnson & Johnson. J&J continues to be dominant in the market through macro-environmental flexibility, industry leadership, and innovation-oriented strategies. The firm's dedication to sustainability and its value to stakeholders enhance its position. The way ahead will be to conduct continuous environmental scanning and develop dynamic capabilities that will make J&J resilient in the changing global healthcare environment.

References

Bird, T., Steffen, J. E., Tran, T. H., & Egilman, D. S. (2021). A Review of the Talc Industry’s Influence on Federal Regulation and Scientific Standards for Asbestos in Talc. NEW SOLUTIONS: A Journal of Environmental and Occupational Health Policy, 31(2), 152–169. https://doi.org/10.1177/1048291121996645

Crain, E. (2023, July 3). 9 Johnson & Johnson innovations that helped drive medicine forward. Content Lab U.S. https://www.jnj.com/9-johnson-&-johnson-innovations-that-helped-drive-medicine-forward

Day Translations, Inc. (2019, April 4). How Johnson & Johnson Globalized Its Medical Devices Line. Day Translations Blog. https://www.daytranslations.com/blog/johnson-global-medical-devices-line/

Johnson & Johnson. (2023, December 5). Johnson & Johnson Announces Key Drivers for Long-Term Competitive Growth at Enterprise Business Review. JNJ.com. https://www.jnj.com/media-center/press-releases/johnson-johnson-announces-key-drivers-for-long-term-competitive-growth-at-enterprise-business-review

Setyadi, A., Pawirosumarto, S., & Damaris, A. (2025). Rethinking Sustainable Operations: A Multi-Level Integration of Circularity, Localization, and Digital Resilience in Manufacturing Systems. Sustainability, 17(15), 6929–6929. https://doi.org/10.3390/su17156929

Wu, X. (2024). Sustainable Development and ESG Initiatives in the Pharmaceutical Industry: A Case Study of Johnson & Johnson Medical Corporation. Advances in Economics, Management and Political Sciences, 71, 233–241. https://doi.org/10.54254/2754-1169/71/20241506